Chronomics Epigenetic Testing: Longitudinal Biological Age Tracking and Lifestyle Impact Measurement

Designed for repeat testing rather than one-time snapshots, Chronomics measures biological age through DNA methylation with a focus on tracking how lifestyle changes move the needle over time.

Presented By Our Partners

The most valuable question in longevity science is not “how old are my cells right now?” but “is what I am doing actually slowing down my aging?” A single biological age measurement, however sophisticated, provides a snapshot. A series of measurements separated by months of intentional lifestyle change provides something far more powerful: a feedback loop between behavior and molecular outcome. A 2018 study by Levine et al. published in the journal Aging demonstrated that DNAm PhenoAge, an epigenetic biomarker incorporating clinical phenotypic data, significantly outperformed earlier clocks in predicting all-cause mortality, cancer, and Alzheimer’s disease across multiple large cohorts. A 2021 study by McCrory et al. in The Journals of Gerontology confirmed GrimAge as the strongest mortality predictor among four major epigenetic clocks, maintaining significance even after adjusting for social and lifestyle confounders in 490 participants followed for a decade. These studies established what epigenetic clocks can measure. Chronomics was built around the next question: can regular measurement of biological age create the accountability and feedback that turns longevity knowledge into longevity practice?

What Is Chronomics?

Chronomics is an at-home epigenetic testing service that measures biological age through DNA methylation analysis from a finger-prick blood sample. The test costs between $299 and $499 depending on the package, and results are delivered through an online dashboard within approximately 4 to 6 weeks. The platform is designed for longitudinal use, with multi-test packages and subscription options that encourage retesting every 3 to 6 months.

The report provides a biological age estimate derived from DNA methylation patterns, a pace of aging metric indicating whether the user is aging faster or slower than expected, and a longitudinal tracking view that compares results across multiple tests. The dashboard also provides lifestyle impact assessments that correlate changes in biological age with self-reported changes in nutrition, exercise, sleep, and stress management between tests.

Chronomics differentiates from competitors by emphasizing the longitudinal journey rather than the initial snapshot. The platform includes personalized action plans based on test results, educational content about the lifestyle factors most strongly associated with epigenetic age modification, and tools for logging health behaviors between tests. The goal is to create a continuous improvement cycle: test, learn, intervene, retest, assess.

The Science Behind It: Epigenetic Clocks as Longitudinal Health Metrics

The scientific foundation of Chronomics is identical to that of TruDiagnostic and Elysium: DNA methylation patterns at specific CpG sites change predictably with age, and the rate of these changes correlates with mortality, disease risk, and functional decline. What distinguishes the longitudinal application is the question of within-person change over time.

The Levine et al. 2018 study in Aging established that PhenoAge predicts all-cause mortality, cancer, and physical functioning across populations. The McCrory et al. 2021 study in The Journals of Gerontology demonstrated that GrimAge age acceleration predicted walking speed, frailty, polypharmacy, and death at 10-year follow-up in 490 participants. A 2022 review by Li et al. in the Journal of Internal Medicine argued that the field should prioritize longitudinal methylation studies to understand how epigenetic changes track with disease development and intervention effectiveness.

The longitudinal application of epigenetic clocks faces a specific technical challenge: test-to-test variability. DNA methylation measurements carry both biological variation (real changes in methylation status) and technical variation (noise from sample processing, laboratory conditions, and array batch effects). For longitudinal tracking to be meaningful, the signal of true biological change must exceed the noise of technical variation. Studies have estimated that the standard error of most epigenetic clocks at the individual level is approximately 3 to 5 years, which means that small changes (1 to 2 years of biological age shift) between tests may fall within the noise margin and should be interpreted cautiously.

Despite this uncertainty, larger and sustained changes, particularly those consistent across multiple test time points, provide more reliable signal. If biological age decreases by 3 or more years across two or three consecutive tests following a sustained lifestyle intervention, the probability that this reflects genuine biological change rather than technical noise increases substantially. That is the science. Here is how Chronomics applies it.

What Chronomics Does Well

Chronomics’ primary strength is its design around the longitudinal use case. While TruDiagnostic and Elysium also recommend retesting, Chronomics has built its entire user experience around the multi-test journey: the dashboard emphasizes trends over time rather than single numbers, the action plans update based on previous results, and the pricing structure incentivizes regular testing through multi-test packages.

The lifestyle impact tracking feature adds a behavioral dimension that pure testing platforms lack. By logging nutrition, exercise, sleep, and stress management practices between tests, users can correlate specific interventions with specific biological age outcomes. This correlation is observational, not causal (many factors change simultaneously), but it provides a structured framework for hypothesis testing about which lifestyle modifications are producing the most significant epigenetic benefits.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

The educational content and personalized action plans help bridge the gap between data and behavior that affects many consumer health testing products. Rather than delivering a biological age number and leaving the user to figure out what to do with it, Chronomics provides structured guidance on evidence-based interventions and tracks whether users are implementing them. This coaching layer, while not as deep as what a functional medicine practitioner would provide, adds practical value above raw data delivery.

Pricing, Access, and Practical Realities

Chronomics pricing ranges from approximately $299 for a single test to $499 for multi-test packages that reduce the per-test cost. Subscription options may be available at further discounted rates for users committing to regular testing cycles. The recommended testing interval is every 3 to 6 months, putting the annual cost for longitudinal tracking at approximately $600 to $1,200 depending on frequency and package selection.

The test uses a finger-prick blood collection kit mailed to a CLIA-certified partner laboratory. Results are delivered within 4 to 6 weeks through a secure online dashboard. No physician order is required. Chronomics is not currently listed as HSA or FSA eligible, and it carries no FDA clearance or medical device designation. Results are informational wellness data.

Chronomics is a smaller company than TruDiagnostic, which introduces considerations about long-term business continuity, laboratory partnerships, and the durability of the platform for multi-year longitudinal tracking. Users planning long-term tracking should consider whether the company’s stability supports a commitment to testing across years rather than months.

Who Chronomics Is Best For

Chronomics is ideal for users who are committed to longitudinal biological age tracking and want a platform built specifically for that purpose. It suits individuals who are actively implementing lifestyle interventions (dietary changes, exercise programs, sleep optimization, stress reduction protocols) and want regular feedback on whether those changes are producing measurable biological results. Health coaches and functional medicine practitioners who want to track client biological age over the course of a coaching engagement will find the longitudinal dashboard and trend visualization useful. Users who are motivated by tracking and accountability, who respond to data-driven feedback loops, will find Chronomics’ design philosophy well-matched to their psychology.

Those who should choose alternatives include users who want the most comprehensive single-test epigenetic panel, as TruDiagnostic TruAge Complete ($499) provides more algorithms (OMICmAge, DunedinPACE, GrimAge, PhenoAge, Horvath), organ-specific ages, and immune cell composition that Chronomics does not match in depth. Anyone seeking a one-time biological age snapshot without commitment to retesting would get more value from TruDiagnostic or Elysium, which do not require longitudinal investment to deliver their primary value. Users interested in immune-specific aging should consider GlycanAge, which provides complementary glycan-based biological age data.

How Chronomics Compares

TruDiagnostic TruAge Complete ($499) offers the deepest single-test epigenetic analysis with multiple named algorithms, organ-specific aging, and the strongest research validation. For single-test depth, TruDiagnostic leads. Chronomics’ advantage is its longitudinal platform design, which provides better tools for tracking trends across multiple tests than TruDiagnostic’s current reporting.

Elysium Index ($299) offers a comparable price point with saliva-based collection and a pace of aging metric. Elysium’s connection to a supplement ecosystem provides an integrated intervention pathway, while Chronomics offers more robust longitudinal tracking tools. myDNAge ($299 to $499) from Zymo Research provides the original Horvath clock with a unique urine collection option but less emphasis on longitudinal tracking. GlycanAge ($299 to $499) measures biological age through a fundamentally different biomarker (IgG glycans) and is complementary rather than competitive with methylation-based services.

The competitive landscape for epigenetic age testing is growing, with all major players converging on the $299 to $499 price point. The key differentiators are algorithmic depth (TruDiagnostic leads), accessibility and sample type (Elysium leads with saliva), longitudinal design (Chronomics leads), and biomarker diversity (GlycanAge provides unique glycan-based data).

Limitations and Open Questions

The test-to-test variability challenge is Chronomics’ most significant scientific limitation. With a standard error of 3 to 5 years for individual measurements, small changes between tests may reflect technical noise rather than genuine biological change. Chronomics addresses this by encouraging multiple data points over time, where trend direction becomes more reliable than any single comparison. However, users should resist over-interpreting the meaning of a 1 to 2 year change between consecutive tests.

The specific methylation algorithm and CpG sites used by Chronomics are proprietary, and the company has published less independent validation data than TruDiagnostic. Without knowing which named clock algorithms underlie the biological age estimate, users cannot directly compare Chronomics results with published research on specific clocks like GrimAge or DunedinPACE.

The lifestyle impact correlation feature, while useful for generating hypotheses, cannot establish causal relationships between specific interventions and biological age changes. Many lifestyle factors change simultaneously, and unmeasured confounders (stress events, illness, medication changes, environmental exposures) may influence methylation patterns independently of tracked behaviors. Users should treat the lifestyle correlation data as hypothesis-generating, not conclusive. The company’s smaller size relative to TruDiagnostic raises questions about the long-term continuity of the platform for users planning multi-year tracking commitments.

What This Means for Your Health

The evidence connecting DNA methylation age to mortality and disease risk is robust and growing. The practical challenge is translating that evidence into behavior change. Within Healthcare Discovery‘s longevity framework, epigenetic age testing serves as the most direct available measurement of whether the Five Pillars, Nutrition, Sleep, Movement, Breathwork, and Mindset, are producing their intended molecular effects. The Four Shadows of cardiovascular disease, cancer, neurodegenerative disease, and metabolic dysfunction all correlate with epigenetic age acceleration, and all are influenced by the same lifestyle factors that modify DNA methylation patterns.

Chronomics’ longitudinal design philosophy aligns with the emerging understanding that the value of biological age testing lies not in any single number but in the trajectory. A biological age of 42 at chronological age 45 is interesting. A trajectory showing biological age declining from 48 to 42 over 18 months of sustained lifestyle intervention is transformative. That trajectory is what Chronomics is designed to measure.

The practical recommendation: if you are serious about long-term biological age tracking and want a platform that makes the trend visible, Chronomics provides the most purpose-built longitudinal experience in the category. If you want the deepest single-test data, TruDiagnostic remains the gold standard. If budget constrains you to a single test, start with TruDiagnostic or Elysium for the most informative baseline, and consider Chronomics when you are ready to commit to repeated measurement over time. The overriding principle remains: the test only matters if it changes what you do. Measure, intervene, remeasure. The feedback loop is the point.

Frequently Asked Questions

How often should I test with Chronomics?
Chronomics recommends testing every 3 to 6 months for meaningful longitudinal tracking. This interval allows sufficient time for lifestyle interventions to produce detectable changes in DNA methylation patterns. At $299 to $499 per test depending on package, users should budget approximately $600 to $1,200 per year for regular monitoring. The first test establishes a baseline; subsequent tests reveal the trajectory.

How does Chronomics compare to TruDiagnostic?
TruDiagnostic TruAge Complete ($499) provides the deepest single-test analysis with multiple named algorithms (OMICmAge, DunedinPACE, GrimAge, PhenoAge, Horvath), organ-specific aging, and immune cell composition. Chronomics ($299 to $499) provides a more streamlined report but with superior longitudinal tracking tools, trend visualization, and lifestyle impact correlation features. For single-test depth, TruDiagnostic leads. For multi-test tracking over time, Chronomics leads.

Can small lifestyle changes really show up in epigenetic age tests?
Large, sustained lifestyle changes (consistent exercise, improved sleep, significant dietary modification) have been associated with measurable shifts in DNA methylation patterns in published research. However, individual epigenetic clocks have a standard error of approximately 3 to 5 years, meaning small changes (1 to 2 years of biological age shift) may fall within the noise margin. The most reliable results come from sustained interventions tracked across multiple test points, where the direction of change becomes more significant than any single measurement.

Is Chronomics a medical test?
No. Chronomics is classified as an informational wellness product, not an FDA-cleared diagnostic device. Results should not be used to diagnose, treat, or prevent disease. Users who discover significant biological age acceleration should consult a healthcare provider for clinical evaluation. The test measures DNA methylation patterns that correlate with health outcomes in population studies, but individual results should be interpreted as one data point within a broader health assessment.

What type of sample does Chronomics require?
Chronomics uses a finger-prick blood collection kit. The at-home collection process takes approximately 5 to 10 minutes, and the sample is mailed to a CLIA-certified partner laboratory in a prepaid mailer. Blood-based methylation analysis is generally considered more standardized than saliva-based analysis (used by Elysium) due to lower cellular heterogeneity in blood samples. Results are typically delivered within 4 to 6 weeks.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.